NOT.DE · NOVARTIS NAM. SF 0,49
Germany · RS rating 63 · As of 2026-10-14
| Price | 131.20 EUR |
|---|---|
| 1-day change | +2.7% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 85 / 45 / 67 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 23 / 50 |
| Industry group (rank) | Medical-Generic Drugs (–) |
| EPS growth Q/Q | +3.6% |
| Sales growth Q/Q | +10.6% |
| Distance from 52-week high | +8.8% |
| Market cap (USD) | $272.0B |